|
|
|
Hospital VeriChip Network |
| |
VeriChip Adds 78
New Hospitals to Its Network at EDPMA Conference
Other Topics: Medical Device RFID,
RFID File Tracking,
RFID Real Time Supply Chain
Business Wire
May 21, 2007
More Than 600 Hospitals Have Now Agreed to Participate in VeriMed
Network
Delray Beach, FL -- VeriChip Corporation (NASDAQ: CHIP), a provider of
RFID systems for healthcare and patient-related needs, announced today
that 78 new hospitals agreed to participate in the VeriMed Patient
Identification System network at the Emergency Department Practice
Management Association’s (EDPMA) tenth annual conference in Las Vegas
on May 16-18. More than 600 hospitals have now agreed to participate
in the VeriMed network. |
| |
|
|
| |
Scott R.
Silverman, Chairman and CEO of VeriChip, commented, “We are very
pleased with the continued acceptance of the VeriMed Patient
Identification system by hospital emergency departments as they
recognize the value it provides in improving patient care. VeriMed’s
footprint continues to grow in regions throughout the U.S. and we
expect to enroll additional hospitals during the remainder of this
year, with a goal of 800 hospitals in our network by year-end.”
The VeriMed Patient Identification System, which consists of a
hand-held radio frequency identification (RFID) scanner, an
implantable RFID microchip, and a secure patient database, is being
used to help rapidly identify and provide access to important health
information on participating patients.
The new healthcare facilities agreed to use the VeriMed reader as
standard protocol to scan patients that arrive in emergency rooms
unconscious, delirious or confused. The Company continues to provide
readers to hospitals and other healthcare facilities at no charge as
part of its efforts to "seed" the infrastructure for the VeriMed
patient identification system.
About VeriChip Corporation
VeriChip Corporation, headquartered in Delray Beach, Florida,
develops, markets and sells radio frequency identification, or RFID,
systems used to identify, locate and protect people and assets.
VeriChip's goal is to become the leading provider of RFID systems for
people in the healthcare industry. VeriChip sells passive RFID systems
for identification purposes and active RFID systems for local-area
location and identification purposes. VeriChip recently began to
market its VeriMed™
Patient Identification System for rapidly and accurately identifying
people who arrive in an emergency room and are unable to communicate.
This system uses the first human-implantable passive RFID microchip,
the implantable VeriChip™,
cleared for medical use in October 2004 by the United States Food and
Drug Administration.
VeriChip Corporation is majority-owned by Applied Digital Inc.
(NASDAQ: ADSX), which also owns a majority position in Digital Angel
Corporation (AMEX: DOC). For more information on VeriChip, please call
1-800-970-2447, or email info@verichipcorp.com. Additional information
can be found online at www.verichipcorp.com.
Statements about the Company's future expectations, including
future revenues and earnings, and all other statements in this press
release other than historical facts are "forward-looking statements"
within the meaning of Section 27A of the Securities Act of 1933,
Section 21E of the Securities Exchange Act of 1934, and as that term
is defined in the Private Litigation Reform Act of 1995. Such
forward-looking statements involve risks and uncertainties and are
subject to change at any time, and the Company's actual results could
differ materially from expected results. The Company undertakes no
obligation to update forward-looking statements to reflect
subsequently occurring events or circumstances. |
| |
|
|
